fluticasone furoate/umeclidinium bromide/vilanterol trifenatate

Mon, 16 Oct 2023 15:46:00 -0400
Long-term, once-daily, maintenance treatment of asthma in patients aged 18 years and older who are not adequately controlled with a maintenance combination of a medium or high dose of an ICS and a LABA.